These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 30666013)

  • 41. Staging of head and neck cancer.
    Ennis RD; Knisely JP; Wilson LD
    N Engl J Med; 1995 Jun; 332(26):1787-8; author reply 1789-90. PubMed ID: 7619166
    [No Abstract]   [Full Text] [Related]  

  • 42. Is a Preoperative Gastrointestinal Endoscopy for Second Primary Cancer Detection in Head and Neck Cancer Necessary? Ten-year Registry Data.
    Heo GM; Kim MH; Kim JH; Rho YS; Shin WG
    Korean J Gastroenterol; 2016 Jul; 68(1):23-8. PubMed ID: 27443620
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Adjuvant treatment for post-operative head and neck squamous cell carcinoma.
    Kiyota N; Tahara M; Fujii M
    Jpn J Clin Oncol; 2015 Jan; 45(1):2-6. PubMed ID: 25411434
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Ki67, p53 and cyclin D1 in the squamous cell carcinoma of head and neck].
    Golusiński W; Golusiński P; Stańczak J; Kłosin J
    Otolaryngol Pol; 2004; 58(4):777-84. PubMed ID: 15603389
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Evaluation of cervical lymph nodes in head and neck cancer with CT and MRI: tips, traps, and a systematic approach.
    Hoang JK; Vanka J; Ludwig BJ; Glastonbury CM
    AJR Am J Roentgenol; 2013 Jan; 200(1):W17-25. PubMed ID: 23255768
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Her2 expression and gene amplification is rarely detectable in patients with oral squamous cell carcinomas.
    Hanken H; Gaudin R; Gröbe A; Fraederich M; Eichhorn W; Smeets R; Simon R; Sauter G; Grupp K; Izbicki JR; Sehner S; Heiland M; Blessmann M
    J Oral Pathol Med; 2014 Apr; 43(4):304-8. PubMed ID: 24645976
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Molecular approaches to the staging of head and neck carcinomas (review).
    Gasparotto D; Maestro R
    Int J Oncol; 2007 Jul; 31(1):175-80. PubMed ID: 17549419
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Use of routine ultrasound-guided fine-needle aspiration cytology to assess the neck in patients with head and neck squamous cell carcinoma.
    Chen JH; Wang CC
    Head Neck; 2012 Nov; 34(11):1678-9; author reply 179. PubMed ID: 22987335
    [No Abstract]   [Full Text] [Related]  

  • 49. Head and neck squamous cancers.
    Jacobs CD; Goffinet DR; Fee WE
    Curr Probl Cancer; 1990; 14(1):1-72. PubMed ID: 2194750
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Loss of p53 expression correlates with metastatic phenotype and transcriptional profile in a new mouse model of head and neck cancer.
    Ku TK; Nguyen DC; Karaman M; Gill P; Hacia JG; Crowe DL
    Mol Cancer Res; 2007 Apr; 5(4):351-62. PubMed ID: 17426250
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Biological predictors of radiosensitivity in head and neck squamous cell carcinoma.
    Fiedler M; Weber F; Hautmann MG; Haubner F; Reichert TE; Klingelhöffer C; Schreml S; Meier JK; Hartmann A; Ettl T
    Clin Oral Investig; 2018 Jan; 22(1):189-200. PubMed ID: 28315964
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Extent of surgical intervention in case of N0 neck in head and neck cancer patients.
    Shah JP
    Eur Arch Otorhinolaryngol; 2004 Jul; 261(6):293-4. PubMed ID: 14714129
    [No Abstract]   [Full Text] [Related]  

  • 53. Metastasis to the submandibular gland in head and neck carcinomas.
    Spiegel JH; Brys AK; Bhakti A; Singer MI
    Head Neck; 2004 Dec; 26(12):1064-8. PubMed ID: 15459920
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Second primary tumours in head and neck cancer.
    Herranz González-Botas J; Varela Vázquez P; Vázquez Barro C
    Acta Otorrinolaringol Esp; 2016; 67(3):123-9. PubMed ID: 26386656
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Staging systems for cancer of the head and neck region--comparison between AJC and UICC.
    Black RJ; Gluckman JL
    Clin Otolaryngol Allied Sci; 1983 Oct; 8(5):305-12. PubMed ID: 6640995
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Head and neck cancer: state of the art.
    Atiyah RA
    J Med Liban; 1994; 42(4):216-20. PubMed ID: 8558581
    [No Abstract]   [Full Text] [Related]  

  • 57. [Analysis of mutations within the TP53 gene in patients with squamous cell carcinoma of the head and neck].
    Golusinski P; Lamperska K; Pazdrowski J; Golusinski W
    Otolaryngol Pol; 2011; 65(2):114-21. PubMed ID: 21735667
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Hypofolatemia as a risk factor for head and neck cancer.
    Paludetti G; Almadori G; Bussu F; Galli J; Cadoni G; Maurizi M
    Adv Otorhinolaryngol; 2005; 62():12-24. PubMed ID: 15608414
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Clinical relevance of immune parameters in the tumor microenvironment of head and neck cancers.
    Wallis SP; Stafford ND; Greenman J
    Head Neck; 2015 Mar; 37(3):449-59. PubMed ID: 24803283
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Characteristics and Limitations of FDG PET/CT for Imaging of Squamous Cell Carcinoma of the Head and Neck: A Comprehensive Review of Anatomy, Metastatic Pathways, and Image Findings.
    Plaxton NA; Brandon DC; Corey AS; Harrison CE; Karagulle Kendi AT; Halkar RK; Barron BJ
    AJR Am J Roentgenol; 2015 Nov; 205(5):W519-31. PubMed ID: 26496574
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.